RENAISSANCE TECHNOLOGIES LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1037389 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,059,666,526

+$129,380,079 QoQ

Shares Held

1,787,019

-6.4% QoQ

Ownership

4.21%

of shares outstanding

% of Portfolio

1.70%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,196,847,717 across 49 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (48.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp This page	1,787,019	$1,059,666,526
2	NBIX	Neurocrine Biosciences Inc	2,418,897	$318,665,490
3	ALKS	Alkermes plc.	6,160,428	$217,832,734
4	RDY	Dr Reddys Laboratories Ltd	7,859,728	$108,857,232
5	SUPN	Supernus Pharmaceuticals, Inc.	1,705,222	$88,142,925
6	TAK	Takeda Pharmaceutical Co Ltd	2,989,100	$55,358,132
7	COLL	Collegium Pharmaceutical, Inc	1,469,449	$48,594,678
8	HIMS	Hims & Hers Health, Inc.	2,118,080	$43,971,340

All Filings in UTHR

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,059,666,526	1,787,019	-6.4%	Shares	Sole	2026-05-14
2025-12-31	$930,286,447	1,909,259	-12.2%	Shares	Sole	2026-02-12
2025-09-30	$911,107,660	2,173,392	+2.6%	Shares	Sole	2025-11-13
2025-06-30	$608,921,086	2,119,092	+0.6%	Shares	Sole	2025-08-13
2025-03-31	$649,522,423	2,106,992	+0.8%	Shares	Sole	2025-05-14
2024-12-31	$737,221,073	2,089,392	-3.1%	Shares	Sole	2025-02-13
2024-09-30	$772,384,723	2,155,392	-0.9%	Shares	Sole	2024-11-13
2024-06-30	$692,748,136	2,174,692	+1.1%	Shares	Sole	2024-08-09
2024-03-31	$494,291,740	2,151,714	-0.9%	Shares	Sole	2024-05-13
2023-12-31	$477,208,356	2,170,214	-3.6%	Shares	Sole	2024-02-13
2023-09-30	$508,322,241	2,250,508	+2.9%	Shares	Sole	2023-11-14
2023-06-30	$482,827,490	2,187,214	-1.8%	Shares	Sole	2023-08-11
2023-03-31	$498,851,639	2,227,414	-5.0%	Shares	Sole	2023-05-12
2022-12-31	$651,979,780	2,344,492	-8.1%	Shares	Sole	2023-02-13
2022-09-30	$533,963,807	2,550,214	-8.7%	Shares	Sole	2022-11-14
2022-06-30	$658,281,783	2,793,591	+1.0%	Shares	Sole	2022-08-12
2022-03-31	$496,106,864	2,765,213	-5.2%	Shares	Sole	2022-05-13
2021-12-31	$630,346,631	2,917,191	-3.7%	Shares	Sole	2022-02-11
2021-09-30	$559,017,326	3,028,591	-2.6%	Shares	Sole	2021-11-12
2021-06-30	$557,999,367	3,110,191	-3.0%	Shares	Sole	2021-08-13
2021-03-31	$536,533,746	3,207,591	-11.1%	Shares	Sole	2021-05-13
2020-12-31	$547,550,700	3,607,291	-2.7%	Shares	Sole	2021-02-10
2020-09-30	$374,610,818	3,709,018	-0.5%	Shares	Sole	2020-11-13
2020-06-30	$450,944,978	3,726,818	+3.8%	Shares	Sole	2020-08-13
2020-03-31	$340,460,847	3,590,223	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.